Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Contemp Clin Trials. 2014 Mar 12;38(1):37–50. doi: 10.1016/j.cct.2014.02.006

Table 3.

Power to detect a 20–30% reduction in asthma and recurrent wheeze for 660 patients in a multi-site study*

Percent reduction in Asthma and/or
Recurrent Wheeze in 4400 IU group

Mean Incidence of Asthma
and/or Recurrent Wheeze in
400 IU group
30% 25% 20%
0.50 0.974 0.906 0.726
0.45 0.950 0.837 0.653
0.40 0.901 0.773 0.574
*

18% LTF and 8% miscarriage rate